Company intelligence / Profile preview

Cancer Populomix Institute

Fredericton, New Brunswick, Canada
Ownership
Private
Development stage
Other
01

Overview

The Cancer Populomix Institute (CPxI) was a Canadian non-profit research organization and biotechnology consortium established in 2006 in Fredericton, New Brunswick. It was formed as a strategic collaboration between the National Research Council of Canada (NRC), the Atlantic Cancer Research Institute (ACRI), and several regional universities, including the University of New Brunswick and Dalhousie University. The institute focused on "populomix," a multidisciplinary approach that combines population health data with molecular "omics" technologies to identify biomarkers for the early detection and prevention of cancer. Its research programs primarily targeted the development of high-accuracy diagnostic tools for prostate, breast, and colon cancers using DNA microarray technology. While the institute was a key driver of the Atlantic Canadian life sciences cluster in the late 2000s, it is no longer active as a standalone entity.

Therapeutic areas
Oncology
Modalities
Molecular diagnosticsBiomarkersDNA microarray
Industry
Academic Hospital/University/Research
02

Partnerships

National Research Council of CanadaAtlantic Cancer Research InstituteUniversity of New BrunswickUniversité de MonctonDalhousie UniversityNew Brunswick Innovation FoundationFred Hutchinson Cancer Research CenterMedMira

Beyond the preview

Go deeper on Cancer Populomix Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer Populomix Institute.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call